Interferon-δ (IFN-δ) belongs to type I IFN. It was first identified by Lefevre in 1993. The porcine interferon-δ (PoIFN-δ)–related sequences were reported in 2009. The IFN-δ-related sequences have not been studied as closely as IFN-α and IFN-β. In this study, we identified 11 functional genes and 7 pseudogenes of the PoIFN-δ-related subtypes from the porcine genome database. Three of these genes were cloned, expressed, and functionally studied. PoIFN-δ-related subtypes can bind to the type I IFN receptors, activate the Janus kinase-signal transduce and activator of transcription (JAK-STAT) signaling pathway, induce IFN stimulate genes, and other cytokines. The antiviral activity of PoIFN-δ-related subtypes varies a lot in different subtypes. Among all the PoIFN-δ subtypes detected, PoIFN-δ8 has the strongest antiviral and immunomodulatory activities.
ChengG, ZhaoX, YanWY, WangWF, ZuoXP, HuangK, LiuY, ChenJ, WangJL, CongW, LiuMQ, GaoHH, ChenJL, LuYG, ZhengZX. 2007. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response. Vaccine, 25,28:5199–5208.
3.
ChoHY, LeeSW, SeoSK, ChoiIW, ChoiI. 2008. Interferon-sensitive response element (ISRE) is mainly responsible for IFN-alpha-induced upregulation of programmed death-1 (PD-1) in macrophages. Biochim Biophys Acta Gene Regul Mech, 1779,12:811–819.
4.
ChoiIS, CollissonEW, MaheswaranSK, YooHS. 2002. Evaluation of cytokine gene expression in porcine spleen cells, peripheral blood mononuclear cells, and alveolar macrophages by competitive RT-PCR. FEMS Immunol Med Microbiol, 34:119–126.
5.
CochetM, VaimanD, LefèvreF. 2009. Novel interferon delta genes in mammals: Cloning of one gene from the sheep, two genes expressed by the horse conceptus and discovery of related sequences in several taxa by genomic database screening. Gene, 433,1–2:88–99.
6.
de WeerdNA, SamarajiwaSA, HertzogPJ. 2007. Type I interferon receptors: biochemistry and biological functions. J Biol Chem, 282,28:20053–20057.
7.
DozoisCM, OswaldE, GautierN, SerthelonJP, FairbrotherJM, OswaldIP. 1997. A reverse transcription-polymerase chain reaction method to analyze porcine cytokine gene expression. Vet Immunol Immunopathol, 58:287–300.
8.
FloresI, MarianoTM, PestkaS. 1991. Human interferon-omega (omega) binds to the alpha/beta-receptor. J Biol Chem, 266,30:19875–19877.
9.
FuXY, KesslerDS, VealsSA, LevyDE, DarnellJE. 1990. ISGF3, the transcriptional activator induced by interferon-alpha, consists of multiple interacting polypeptide-chains. Proc Natl Acad Sci U S A, 87,21:8555–8559.
10.
HallerO, KochsG, WeberF. 2006. The interferon response circuit: Induction and suppression by pathogenic viruses. Virology, 344,1:119–130.
11.
HanCS. 2001. Antiviral activities of the soluble extracellular domains of type I interferon receptors. Proc Natl Acad Sci U S A, 98,11:6138–6143.
12.
IhleJN. 1996. STATs: Signal transducers and activators of transcription. Cell, 84,3:331–334.
13.
IsaacsA, LindenmannJ, ValentineRC. 1957. Virus interference. 2. Some properities of interferon. Proc R Soc Lond Ser B Biol Sci, 147,927:268–273.
14.
KotenkoSV, GallagherG, BaurinVV, Lewis-AntesA, ShenML, ShahNK, LangerJA, SheikhF, DickensheetsH, DonnellyRP. 2003. IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol, 4,1:69–77.
15.
KrauseC, PestkaS. 2005. Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives. Pharmacol Ther, 106,3:299–346.
16.
LaFleurDW, NardelliB, TsarevaT, MatherD, FengP, SemenukM, TaylorK, BuerginM, ChinchillaD, RoshkeV, ChenGX, RubenSM, PithaPM, ColemanTA, MoorePA. 2001. Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J Biol Chem, 276,43:39765–39771.
17.
LefevreF, BoulayV. 1993. A novel and atypical type one interferon gene expressed by trophoblast during early-pregnancy. J Biol Chem, 268,26:19760–19768.
18.
LefevreF, GuillomotM, D'AndreaS, BattegayS, La BonnardiereC. 1998. Interferon-delta: the first member of a novel type I interferon family. Biochimie, 80,8–9:779–788.
OritaniK, TomiyamaY. 2004. Interferon-zeta/limitin: Novel type I interferon that displays a narrow range of biological activity. Int J Hematol, 80,4:325–331.
21.
PestkaS, KrauseCD, WalterMR. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol Rev, 202:8–32.
22.
PestkaS, LangerJA, ZoonKC, SamuelCE. 1987. Interferons and their actions. Annu Rev Biochem, 56:727–777.
23.
Quadt-AkabayovSR, ChillJH, LevyR, KesslerN, AnglisterJ. 2006. Determination of the human type I interferon receptor binding site on human interferon-alpha 2 by cross saturation and an NMR-based model of the complex. Protein Sci, 15,11:2656–2668.
24.
RandallRE, GoodbournS. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol, 89:1–47.
25.
SangYM, RowlandRRR, HesseRA, BlechaF. 2010. Differential expression and activity of the porcine type I interferon family. Physiol Genomics, 42,2:248–258.
26.
SchultzU, KaspersB, StaeheliP. 2004. The interferon system of non-mammalian vertebrates. Dev Comp Immunol, 28,5:499–508.
27.
SheppardP, KindsvogelW, XuWF, HendersonK, SchlutsmeyerS, WhitmoreTE, KuestnerR, GarriguesU, BirksC, RorabackJ, OstranderC, DongD, ShinJ, PresnellS, FoxB, HaldemanB, CooperE, TaftD, GilbertT, GrantFJ, TackettM, KrivanW, McKnightG, CleggC, FosterD, KlucherKM. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol, 4,1:63–68.
28.
TaniguchiT, TakaokaA. 2001. A weak signal for strong responses: Interferon-α/β revisited. Nat Rev Mol Cell Biol, 2:378–386.
29.
van PeschV, MichielsT. 2003. Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J Biol Chem, 278,47:46321–46328.
30.
ZhaoX, ChengG, YanWY, LiuMQ, HeY, ZhengZX. 2009. Characterization and virus-induced expression profiles of the porcine interferon-omega multigene family. J Interferon Cytokine Res, 29,10:687–693.
